Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Dig Dis Sci ; 64(8): 2368, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31300996

RESUMEN

The Editor-in-Chief has retracted this article [1] because Figure 3c appears to have been modified and reused as Figure 3d.

2.
Dig Dis Sci ; 57(7): 1838-46, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22451114

RESUMEN

BACKGROUND: HAX-1 is an anti-apoptotic factor and regulates the expression of DNA pol ß. Interestingly, DNA polymerase pol ß is overexpressed in esophageal squamous cell carcinoma (ESCC). However, the functional role of HAX-1 in ESCC remains unclear. AIMS: To investigate the role of HAX-1 in chemoresistance, invasion, and tumorigenicity of ESCC. METHODS: Lentivirus-mediated overexpression or knockdown of HAX-1 was employed to establish ESCC EC9706 cell lines that expressed HAX-1 at different levels. The biological behaviors of these engineered cells were characterized in vitro and in vivo using a xenograft nude mice model. In addition, HAX-1 and pol ß expression in the tumor tissues was detected by RT-PCR and immunohistochemistry. RESULTS: HAX-1 overexpression promoted cell proliferation and resistance against cisplatin, increased cell invasion and suppressed apoptosis along with increased pol ß expression. Conversely, HAX-1 knockdown inhibited the malignant phenotypes of EC9706 cells. The xenograft nude mice model demonstrated that HAX-1 overexpression or depletion led to increased or decreased tumor growth in vivo, respectively. Furthermore, a positive correlation of HAX-1 and pol ß expression in the tumor tissues was observed. CONCLUSIONS: HAX-1 promotes the proliferation, chemoresistance, invasion, and tumorigenicity of ESCC, and this is correlated with increased poly ß expression. HAX-1 may represent a potential target to overcome the resistance and metastasis of ESCC.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/fisiología , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/fisiopatología , Transformación Celular Neoplásica/patología , Resistencia a Antineoplásicos/fisiología , Neoplasias Esofágicas/patología , Neoplasias Esofágicas/fisiopatología , Proteínas Adaptadoras Transductoras de Señales/efectos de los fármacos , Proteínas Adaptadoras Transductoras de Señales/genética , Animales , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Cisplatino/farmacología , Cisplatino/uso terapéutico , Modelos Animales de Enfermedad , Neoplasias Esofágicas/tratamiento farmacológico , Femenino , Células HEK293 , Humanos , Técnicas In Vitro , Ratones , Ratones Desnudos , Invasividad Neoplásica/fisiopatología , ARN Interferente Pequeño/farmacología , Trasplante Heterólogo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...